Study record

Mitochondrial-derived microprotein MOTS-c attenuates immobilization-induced skeletal muscle atrophy by suppressing lipid infiltration

Kumagai H, Kim SJ, Miller B et al. · Am J Physiol Endocrinol Metab · 2024

AnimalMOTS-c administeredEvidence tier C

What this study reported

Reported that immobilisation reduced muscle mass by about 15% in mice, whereas mice given administered MOTS-c lost about 5%. In the same mice, MOTS-c was associated with normalised phospho-AKT, phospho-FOXO1 and phospho-FOXO3a, lower circulating IL-1β, IL-6, CXCL1 and MCP-1, and lower muscle fatty acid levels, with transcriptomic changes in PPAR-pathway adipogenesis genes.

Limitations

Single strain, males only and a short experimental window; group sizes and blinding are not reported; exposure is supraphysiological and only one atrophy model was tested.

Study record

Annotated fields for this study
Study modelAnimal study (in vivo)
Substance studiedMOTS-c administeredSynthetic MOTS-c was given to cells, animals or people.
Speciesmouse
System studiedMale C57BL/6J mice with casting-induced hindlimb immobilisation
PopulationNot reported
DesignControlled animal experiment
Sample size as reportedNot reported
Control groupimmobilised mice given vehicle injections and non-immobilised controls
Route (data field only)Not reported
Endpoints measuredskeletal muscle mass; AKT and FOXO phosphorylation; circulating inflammatory cytokines; muscle fatty acid content; muscle transcriptome
Pathways measuredAKT / mTOR / FOXO · Inflammation · Lipid metabolism
Research areasSkeletal muscle · Metabolic
Evidence tierC — Animal in vivo
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Mammalian
Sample size
Not reported
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.